In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 null mutant

被引:12
|
作者
Cauthen, AN
Brown, CC
Spindler, KR
机构
[1] Univ Georgia, Dept Genet, Franklin Coll Arts & Sci, Athens, GA 30602 USA
[2] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA 30602 USA
关键词
D O I
10.1128/JVI.73.10.8640-8646.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previous attempts to construct a mouse adenovirus type 1 early region 3 (E3) null mutant by initiator codon mutagenesis were unsuccessful because one of the E3 proteins, gp11K, is synthesized as a fusion protein from a late viral mRNA (A. N. Cauthen and K. R. Spindler, Virology 259:119-128, 1999). Therefore, a different mutagenesis strategy was employed that inserted termination codons into all three reading frames of the E3 proteins. This strategy produced a mutant, pmE314, that was null for the expression of E3 proteins as determined by immunoprecipitation with E3-specific antisera, This mutant grew as well as wild-type (wt) virus in both 3T6 mouse fibroblasts and mouse brain microvascular endothelial cells. However, the 50% lethal dose for pmE314 in adult NM Swiss outbred mice was approximately 6 log units higher than that of wt virus, indicating that pmE314 was less virulent in mice, In situ hybridization experiments revealed that the absence of the E3 proteins did not alter the tropism of the mutant virus from that of wt virus. When the histopathology was evaluated, the characteristics of the pmE314 infection at both doses administered were strikingly different from those exhibited by wt virus, The central nervous system of wt-infected mice exhibited damage to the endothelium and recruitment of inflammatory cells, whereas the central nervous system of pmE314-infected mice showed no inflammatory response and only mild signs of endothelial damage.
引用
收藏
页码:8640 / 8646
页数:7
相关论文
共 50 条
  • [41] Characterization of the VPAC1 null mouse
    O'Dorisio, M. S.
    Karacay, B.
    Fabricius, D.
    Shutt, D.
    Khanna, G.
    Thedens, D.
    Desmond, M.
    Yang, B.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2007, 33 (03) : 322 - 322
  • [42] Genetic organization and DNA sequence of early region 4 of bovine adenovirus type 3
    Lee, JB
    Baxi, MK
    Idamakanti, N
    Reddy, PS
    Zakhartchouk, AN
    Pyne, C
    Babiuk, LA
    Tikoo, SK
    VIRUS GENES, 1998, 17 (01) : 99 - 100
  • [43] SEQUENCE AND GENETIC ORGANIZATION OF ADENOVIRUS TYPE-35 EARLY REGION-3
    FLOMENBERG, PR
    CHEN, M
    HORWITZ, MS
    JOURNAL OF VIROLOGY, 1988, 62 (11) : 4431 - 4437
  • [44] Genetic Organization and DNA Sequence of Early Region 4 of Bovine Adenovirus Type 3
    Joong B. Lee
    Mohit K. Baxi
    Neeraja Idamakanti
    P. Seshidhar Reddy
    Alexandre N. Zakhartchouk
    C. Pyne
    Lorne A. Babiuk
    Suresh K. Tikoo
    Virus Genes, 1998, 17 : 99 - 100
  • [45] Mouse adenovirus type 1 infection of macrophages
    Ashley, Shanna L.
    Welton, Amanda R.
    Harwood, Kirsten M.
    Van Rooijen, Nico
    Spindler, Katherine R.
    VIROLOGY, 2009, 390 (02) : 307 - 314
  • [46] PHYSICAL ORGANIZATION OF THE ENTERIC ADENOVIRUS TYPE-41 EARLY REGION-1A
    ALLARD, A
    WADELL, G
    VIROLOGY, 1988, 164 (01) : 220 - 229
  • [47] AN IMMUNODOMINANT DOMAIN IN ADENOVIRUS TYPE-2 EARLY REGION-1A PROTEINS
    TSUKAMOTO, AS
    FERGUSON, B
    ROSENBERG, M
    WEISSMAN, IL
    BERK, AJ
    JOURNAL OF VIROLOGY, 1986, 60 (01) : 312 - 316
  • [48] Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro
    Campeau, Lysanne
    Fuellhase, Claudius
    Sawada, Norifumi
    Gratzke, Christian
    Hedlund, Petter
    Howlett, Allyn C.
    Andersson, Karl-Erik
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (05) : 566 - 570
  • [49] ELECTROPHORETIC AND SPECTRAL CHARACTERIZATION OF WILD-TYPE AND MUTANT ADENOVIRUS PROTEASE
    KEYVANIAMINEH, H
    DIOURI, M
    GUILLEMETTE, JG
    WEBER, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23250 - 23253
  • [50] CHARACTERIZATION OF A DNA-NEGATIVE MUTANT OF TYPE-2 ADENOVIRUS
    ULLRICH, K
    PFITZINGER, I
    WINNACKER, EL
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1981, 169 (02) : 115 - 115